chemXplore tracks 22 projects in Ireland, of which 3 are active.
Of the active ones, 2 expansion and 1 new construction.
The dates themselves, per project, are for subscribers.
Interim Phase III DASL-HiCaP results show darolutamide added to ADT and radiation significantly improves metastasis-free survival versus placebo in high‑risk patients.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
Showcased quality, global dual‑sourcing and European capacity (Dundalk 54,000 L, Wuppertal 12–24,000 L) alongside platform speeds for complex biologics and 1,064 active projects.
€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.
CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.
SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.
Study finds Europe needs a step-change in exploration spending and permitting reform to convert geological potential into domestic critical raw materials supply.
€25m anchor aims to mobilise €100m for Seed/Series A agrifood tech; 30% earmarked for Ireland. Article 9 SFDR fund with 90% climate/environment target.
John Smith will lead EMEA architectural coatings from July 1, 2026; Steve Pocock retires June 30, 2026.
CRCF Days launched rollout: certification schemes may seek CRCF recognition; Buyers’ Club to aggregate demand; removals and carbon‑farming methodologies near adoption; financing and de‑risking needed
active / all projects
